These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34659334)

  • 1. Identification of Gene Signature as Diagnostic and Prognostic Blood Biomarker for Early Hepatocellular Carcinoma Using Integrated Cross-Species Transcriptomic and Network Analyses.
    Al-Harazi O; Kaya IH; Al-Eid M; Alfantoukh L; Al Zahrani AS; Al Sebayel M; Kaya N; Colak D
    Front Genet; 2021; 12():710049. PubMed ID: 34659334
    [No Abstract]   [Full Text] [Related]  

  • 2. Transcriptomic data analysis coupled with copy number aberrations reveals a blood-based 17-gene signature for diagnosis and prognosis of patients with colorectal cancer.
    Kaya IH; Al-Harazi O; Colak D
    Front Genet; 2022; 13():1031086. PubMed ID: 36685857
    [No Abstract]   [Full Text] [Related]  

  • 3. Integrated Analysis of Transcriptomic and Genomic Data Reveals Blood Biomarkers With Diagnostic and Prognostic Potential in Non-small Cell Lung Cancer.
    Kaya IH; Al-Harazi O; Kaya MT; Colak D
    Front Mol Biosci; 2022; 9():774738. PubMed ID: 35309509
    [No Abstract]   [Full Text] [Related]  

  • 4. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach.
    Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Gene-Set Signature in Early-Stage Hepatocellular Carcinoma and Relevant Immune Characteristics.
    Zhao Q; Wongpoomchai R; Chariyakornkul A; Xiao Z; Pilapong C
    Front Oncol; 2021; 11():740484. PubMed ID: 34745960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Potential Hub Genes Related to Diagnosis and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma via Integrated Bioinformatics Analysis.
    Tang Y; Zhang Y; Hu X
    Biomed Res Int; 2020; 2020():4251761. PubMed ID: 33376723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Gene Signatures for Diagnosis and Prognosis of Hepatocellular Carcinomas Patients at Early Stage.
    Gan X; Luo Y; Dai G; Lin J; Liu X; Zhang X; Li A
    Front Genet; 2020; 11():857. PubMed ID: 32849835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma.
    Peng Y; Liu C; Li M; Li W; Zhang M; Jiang X; Chang Y; Liu L; Wang F; Zhao Q
    Cancer Cell Int; 2021 Feb; 21(1):98. PubMed ID: 33568167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma.
    Wang Z; Zhu J; Liu Y; Liu C; Wang W; Chen F; Ma L
    J Transl Med; 2020 Feb; 18(1):67. PubMed ID: 32046766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of the competing endogenous circRNA-lncRNA-miRNA-mRNA network and identification of a novel potential biomarker for hepatocellular carcinoma.
    Zhang L; Tao H; Li J; Zhang E; Liang H; Zhang B
    Aging (Albany NY); 2021 May; 13(12):15990-16008. PubMed ID: 34049287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An epithelial-mesenchymal transition-related 5-gene signature predicting the prognosis of hepatocellular carcinoma patients.
    Zhu G; Xia H; Tang Q; Bi F
    Cancer Cell Int; 2021 Mar; 21(1):166. PubMed ID: 33712026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a 14-gene signature for prognosis prediction in hepatocellular carcinoma.
    Zhang BH; Yang J; Jiang L; Lyu T; Kong LX; Tan YF; Li B; Zhu YF; Xi AY; Xu X; Yan LN; Yang JY
    Genomics; 2020 Jul; 112(4):2763-2771. PubMed ID: 32198063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of 40S ribosomal protein S8 as a novel biomarker for alcohol‑associated hepatocellular carcinoma using weighted gene co‑expression network analysis.
    Bi N; Sun Y; Lei S; Zeng Z; Zhang Y; Sun C; Yu C
    Oncol Rep; 2020 Aug; 44(2):611-627. PubMed ID: 32627011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma.
    Zhang X; Ma L; Zhai L; Chen D; Li Y; Shang Z; Zhang Z; Gao Y; Yang W; Li Y; Pan Y
    Int J Med Sci; 2021; 18(4):984-999. PubMed ID: 33456356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening and identification of angiogenesis-related genes as potential novel prognostic biomarkers of hepatocellular carcinoma through bioinformatics analysis.
    Zhen Z; Shen Z; Hu Y; Sun P
    Aging (Albany NY); 2021 Jul; 13(13):17707-17733. PubMed ID: 34252885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-adjacent tissue co-expression profile analysis reveals pro-oncogenic ribosomal gene signature for prognosis of resectable hepatocellular carcinoma.
    Grinchuk OV; Yenamandra SP; Iyer R; Singh M; Lee HK; Lim KH; Chow PK; Kuznetsov VA
    Mol Oncol; 2018 Jan; 12(1):89-113. PubMed ID: 29117471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Differential analysis of gene expression profiles in hepatocellular carcinoma patients with high and low levels of alpha-fetoprotein].
    Wang XJ; Shen RF; Wang X; Wang YR; Xiao T
    Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):396-402. PubMed ID: 32482029
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of prognostic claudins signature in hepatocellular carcinoma from a hepatocyte differentiation model.
    Kong FE; Tang YQ; Gong YF; Mo JQ; Zhao Y; Li MM; Cheng W; Li HL; Zhu WJ; Liu SS; Huang L; Guan XY; Ma NF; Liu M
    Hepatol Int; 2020 Jul; 14(4):521-533. PubMed ID: 32304089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.